SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (664)12/18/1998 7:34:00 PM
From: steve kammerer  Read Replies (3) | Respond to of 1906
 
The suit was over rights to a new version of Epogen. They can market it worldwide except Japan. Now all they have to do is win the patent infringement suit on same molecule with another company and Amgen will be home free.
stevek



To: Henry Niman who wrote (664)12/21/1998 8:56:00 AM
From: Mel Spivak  Read Replies (1) | Respond to of 1906
 
Great news for AMGN. This AM, another drug stock got great news, PGNS Pathogenisis announced these amazing results: biz.yahoo.com